We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NCI Announces Six Awards to Evaluate Cancer Signatures Program

News   Nov 29, 2005

 
NCI Announces Six Awards to Evaluate Cancer Signatures Program
 
 
Advertisement
 

RELATED ARTICLES

CRISPR-Based Malaria Testing on the Fly

News

A multi-disciplinary research collaboration created a field-applicable, ultrasensitive diagnostic assay that specifically detects DNA sequences from all Plasmodium species in symptomatic and asymptomatic malaria.

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

Insights Into Therapeutic Mechanisms of Cancer Drug Pomalidomide

News

Researchers report novel findings concerning the therapeutic mechanisms of pomalidomide. They showed that pomalidomide causes the breakdown of a protein called ARID2. ARID2 promotes the "expression" of genes that are critical for the growth of multiple myeloma cells, so breaking down ARID2 is harmful to the cancer cells and beneficial to patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE